BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 9477131)

  • 21. The search for meaning in monoclonal protein. Is it multiple myeloma or monoclonal gammopathy of undetermined significance?
    Brigden ML
    Postgrad Med; 1999 Aug; 106(2):135-42; quiz 185. PubMed ID: 10456045
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The predictive power of serum kappa/lambda ratios for discrimination between monoclonal gammopathy of undetermined significance and multiple myeloma.
    Bergón E; Miravalles E; Bergón E; Miranda I; Bergón M
    Clin Chem Lab Med; 2005; 43(1):32-7. PubMed ID: 15653439
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic criteria of multiple myeloma.
    Kyle RA
    Hematol Oncol Clin North Am; 1992 Apr; 6(2):347-58. PubMed ID: 1582977
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunological methods in the diagnosis of monoclonal gammopathies. The prognostic impact of the immunological data.
    Baldea L; Cucuianu A; Cristea A
    Rom J Intern Med; 1999; 37(3):217-25. PubMed ID: 15532300
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Multiple myeloma with D immunoglobulin].
    Benchekroun L; Ouzzif Z; Bouabdillah M; Jaouhar N; Aoufir F; Aoufi F; Chabraoui L
    Ann Biol Clin (Paris); 2011; 69(5):581-7. PubMed ID: 22008139
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selection of patients with monoclonal gammopathy of undetermined significance is mandatory for a reliable use of interleukin-6 and other nonspecific multiple myeloma serum markers.
    Greco C; Ameglio F; Alvino S; Cianciulli AM; Giovannelli M; Mattei F; Vitelli G; Venturo I; Lopez M; Gandolfo GM
    Acta Haematol; 1994; 92(1):1-7. PubMed ID: 7985475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum free light chains in the diagnosis and monitoring of patients with plasma cell dyscrasias.
    Mayo MM; Johns GS
    Contrib Nephrol; 2007; 153():44-65. PubMed ID: 17075223
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Immunoglobulin D lambda multiple myeloma: a case report].
    Qiao SK; Zhang XJ; Wang FX; Pan L; Yao L; Dong ZR
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Jun; 15(3):643-6. PubMed ID: 17605885
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lymphoplasmacytic Lymphoma with IgA Paraproteinemia.
    Guan J; Fang F; Shao Z
    Clin Lab; 2015; 61(7):835-7. PubMed ID: 26299085
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Study of cellular immunology in malignant and benign monoclonal gammapathies].
    Gasparotto G; Semenzato G; Tosato F; Cazzaro G; Amadori G
    Schweiz Med Wochenschr; 1976 Dec; 106(50):1823-5. PubMed ID: 1087754
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunoglobulin A monoclonal gammopathy in two horses with multiple myeloma.
    Pusterla N; Stacy BA; Vernau W; De Cock HE; Magdesian KG
    Vet Rec; 2004 Jul; 155(1):19-23. PubMed ID: 15264485
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Usefulness of a free light chain immunoassay in serum for the diagnosis and the follow-up of monoclonal gammopathy].
    Guenet L; Decaux O; Lechartier H; Ropert M; Grosbois B
    Rev Med Interne; 2007 Oct; 28(10):689-97. PubMed ID: 17566612
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heavy/light chain assay as a biomarker for diagnosis and follow-up of multiple myeloma.
    Chae H; Han E; Yoo J; Lee J; Lee JJ; Cha K; Kim M; Kim Y; Lee SE; Min CK
    Clin Chim Acta; 2018 Apr; 479():7-13. PubMed ID: 29324245
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Nephropathy in a patient with IgD-myeloma].
    Dimitrakov D; Karastanev I; Diukmedzhiev I; Goranov S
    Vutr Boles; 1979; 18(1):93-6. PubMed ID: 433257
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IgD-λ myeloma with extensive free light-chain excretion: a diagnostic pitfall in the identification of monoclonal gammopathies.
    Robier C; Piribauer M; Beham-Schmid C; Aubell K; Neubauer M
    Clin Chem Lab Med; 2017 Jun; 55(7):e137-e139. PubMed ID: 27816953
    [No Abstract]   [Full Text] [Related]  

  • 36. N-glycosylation of serum proteins for the assessment of patients with IgD multiple myeloma.
    Chen J; Fang M; Chen X; Yi C; Ji J; Cheng C; Wang M; Gu X; Sun Q; Gao C
    BMC Cancer; 2017 Dec; 17(1):881. PubMed ID: 29268706
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Monoclonal gammopathies of undetermined significance].
    Zandecki M; Geneviève F; Jego P; Grosbois B
    Rev Med Interne; 2000 Dec; 21(12):1060-74. PubMed ID: 11191674
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Diagnostic problems in monoclonal gammopathies].
    Tilz GP; Becker H; Lanzer G
    Acta Med Austriaca; 1982; 9(4):139-42. PubMed ID: 6814156
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The CBO professional guideline 'monoclonal gammopathy' (paraproteinemia) (revision)].
    Buiting AM; Wijermans PW
    Ned Tijdschr Geneeskd; 2002 Jul; 146(30):1406-11. PubMed ID: 12174434
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Monoclonal gammopathy in HIV infection].
    Löhr HF; Ramadori G; Mayet WJ; Hess G; Meyer zum Büschenfelde KH
    Dtsch Med Wochenschr; 1989 Jul; 114(27):1069-72. PubMed ID: 2472260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.